CyberSecBulletin
CVE-2026-123218Exploited in the wildNVD status: Analyzed

IBM Aspera Faspex Incorrect Authorization

CVE-2026-123218 is a critical-severity incorrect authorization vulnerability in Aspera Faspex from IBM, with a CVSS 3.1 base score of 9.8 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. Affected Aspera Faspex versions: 5.0.0 through 5.0.19. The record does not name a fixed version, so check the vendor advisory. CISA added it to the Known Exploited Vulnerabilities catalogue on November 9, 2026, which means attacks have been observed in the wild.

Patch now

Attackers are already exploiting this vulnerability, according to CISA.

What to do

  1. Check which version of Aspera Faspex you run against the affected versions below, and install the vendor's latest release.
  2. CISA's required action: Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
  3. Read the advisory on ibm.com for workarounds and exact fixed builds.
  4. Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.

Affected products and versions

VendorProductAffected versionsFixed in
IBMAspera Faspex5.0.0 through 5.0.19Not stated

Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.

How the severity score breaks down

Attack vector
NetworkCan be exploited remotely over a network, including the internet.
Attack complexity
LowNo special conditions are needed; the attack works reliably.
Privileges required
NoneNo account or login is needed.
User interaction
NoneNo action by a victim is required.
Scope
UnchangedImpact stays within the vulnerable component.
Confidentiality
HighAll data handled by the component can be read.
Integrity
HighData or code can be modified at will.
Availability
HighThe component can be taken down completely.

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. Scored by CNA (us.ibm.com).

Official description

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

Source: the CVE record as published by its numbering authority, via NVD and CVE.org.

The underlying weakness: Incorrect Authorization

The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check.

How developers prevent this class of flaw

  • Divide the product into anonymous, normal, privileged, and administrative areas. Reduce the attack surface by carefully mapping roles with data and functionality. Use role-based access control (RBAC) to enforce the roles at the appropriate boundaries. Note that this approach may not protect against horizontal authorization, i.e., it will not protect a user from attacking others with the same role.
  • Ensure that access control checks are performed related to the business logic. These checks may be different than the access control checks that are applied to more generic resources such as files, connections, processes, memory, and database records. For example, a database may restrict access for medical records to a specific database user, but each record might only be intended to be accessible to the patient and the patient's doctor.
  • Use a vetted library or framework that does not allow this weakness to occur or provides constructs that make this weakness easier to avoid. For example, consider using authorization frameworks such as the JAAS Authorization Framework and the OWASP ESAPI Access Control feature.

More Incorrect Authorization vulnerabilities (CWE-863)

Timeline

  1. CVE record published.
  2. CISA published its SSVC assessment (exploitation: active, automatable: yes, technical impact: total).
  3. Added to CISA's Known Exploited Vulnerabilities catalogue.
  4. Record last changed materially (score, affected products, status or references).
  5. Deadline for US federal agencies to remediate, set by CISA.

References

Third-party and government advisories

Our coverage

Other vulnerabilities in Aspera Faspex

All Aspera Faspex vulnerabilities

Recent Incorrect Authorization vulnerabilities

Spotted an error? Tell us.